Introduction {#Sec1}
============

Total hip arthroplasty (THA) is one of the most common and successful surgeries in orthopedics, with a 2007 Lancet article dubbing it "the operation of the century." \[[@CR1]\] Further, the demand for THA is growing, given the world's aging population and consequential rise in osteoarthritis \[[@CR2]\]. Over the last decade, major developments have been occurring throughout the orthopedic field, and specifically in the realm of arthroplasty, including the transition to fast-track and outpatient-based surgery, as well as the introduction of navigational and robotic-assisted surgeries.

Studies show that THA is shifting to the outpatient setting worldwide, with estimates showing that by 2026, more than half of THAs in the USA will be performed as an outpatient procedure \[[@CR3], [@CR4]\]. This transition has been enabled by various factors including the rise in multidisciplinary care coordination, standardization of perioperative protocols, and development of rapid rehabilitation protocols \[[@CR5]--[@CR7]\]. As the main concern of outpatient THA is patient safety, several studies have investigated immediate and delayed postoperative complications, with a systematic review finding equivalent complications between outpatient and inpatient arthroplasty \[[@CR8]\].

There is limited literature on PROs comparing outpatient THA (oTHA) and inpatient THA (iTHA). The purpose of this study was to compare prospectively collected 2-year outcomes and 90-day complications in 100 consecutive patients undergoing oTHA with a matched cohort of 100 patients undergoing iTHA. Our hypothesis was that patients undergoing outpatient surgery would demonstrate higher postoperative PROs, while not incurring higher complication or revision rates.

Methods {#Sec2}
=======

The first 100 consecutive patients who underwent oTHA at our institution were group matched to 100 patients who underwent iTHA during the same time period: July 2014 to April 2016. Outpatient cases were matched to inpatient cases with similar age, sex, BMI, laterality, approach, Charlson Comorbidity Index (CCI), and smoking status via propensity score matching.

The CCI was used to assess comorbid diseases in the outpatient and inpatient groups. This index generates a numerical score incorporating the following variables: age, myocardial infarction, chronic heart failure (CHF), peripheral vascular disease, cerebrovascular accident (CVA), dementia, chronic obstructive pulmonary disease (COPD), connective tissue disease, peptic ulcer disease, liver disease, diabetes mellitus, hemiplegia, chronic kidney disease (CKD), cancer, and AIDS \[[@CR9]\]. In addition, the American Society of Anesthesiologists (ASA) Score was used to assess the physical status of patients before surgery. ASA scores were defined as follows: 1: normal healthy patient, 2: patient with mild systemic disease, 3: patient with severe systemic disease, and 4: patient with severe systemic disease that is a constant threat to life \[[@CR10]\]. In addition, smoking status was recorded as it has been shown to increase the risk of inpatient complications, costs, and length of stay following THA \[[@CR11]--[@CR13]\].

A total of 8 patient-reported outcomes (PROs) were provided for both groups: Harris Hip Score (HHS), modified Harris Hip Score (mHHS), Forgotten Joint Score (FJS), the physical and mental components of the Veterans Rand-12 Item Health Survey (VR-12P and VR-12M, respectively), the physical and mental components of the Short Form (SF-12P and SF-12M, respectively), and a visual analog pain scale (VAS) for pain. In addition, satisfaction with surgery was reported, with 0 being the least satisfied and 10 being the most satisfied. For FJS, the proportion of patients attaining the previously published "successful" threshold was determined for each group \[[@CR14]\]. Perioperative outcomes were collected including surgical time and blood loss, length of hospitalization, and radiographic placement of components. In addition, unplanned office visits in the first 90 days following surgery, revision surgeries, and complications were noted for both groups. Complications were classified according to the Clavien-Dindo classification system \[[@CR15], [@CR16]\].

In order to detect an 8-point difference in HHS, a priori power analysis indicated a sample size of 82 in each group was necessary to detect statistical significance between groups with at least 80% power \[[@CR17]\]. In order to allow for exclusions and loss to follow-up, an initial group size of 100 patients was chosen.

All statistical analysis was performed using Microsoft Excel (Microsoft Corporation; Redmond, WA) and the Real Statistics Add-In. Data was assessed for normality using the Shapiro-Wilk Test and was assessed for equal variance using the *F* test. Normally distributed data sets were compared using the Student's *T* test. The Mann-Whitney and Welch test were used to compare non-normally distributed data with equal and unequal variances, respectively. Categorial variables were assessed with the chi-square test or Fisher's exact test. The threshold for statistical significance was set at *P* \< 0.05.

While the present study represents a unique analysis, data on some patients in this study has been reported in other studies. All data collection received Institutional Review Board approval.

Indications for outpatient THA {#Sec3}
------------------------------

All patients underwent a comprehensive physical examination and radiographic evaluation by the senior surgeon (BGD). At our institution, beginning in 2014, all patients without significant comorbidities were offered the option of outpatient THA, and the decision whether to proceed with an outpatient procedure was based on patient preference. All patients had hip osteoarthritis which impaired their activities of daily living and were refractory to a minimum of 3 months of conservative treatment (rest, activity modification, physical therapy, and non-steroidal anti-inflammatory drugs).

Surgical technique {#Sec4}
------------------

Preoperative planning based on anteriorposterior (AP) plain radiography using the TraumaCad software (Brainlab, Munich, Germany) was performed. Using the MAKO^TM^ robotic-arm-assisted total hip system (Stryker Orthopaedics, Mahwah, NJ), an additional 3-dimensional model was built during preoperative planning based on computed tomography (CT) scans. Prior to surgery, the senior surgeon (BGD) used this model to facilitate surgical planning and to achieve restoration of patient-specific leg length and global offset.

The preferred surgical approach was the direct anterior approach; although, patients with an associated gluteus medius tear or in the need of hardware removal underwent a THA with the posterior approach. On the day of surgery, general anesthesia and intravenous tranexamic acid (10 mg/kg) were administered prior to incision. The operative hip was prepared and draped in a sterile fashion. After performing the capsulotomy, femoral registration was performed followed by a robotic-assisted femoral neck cut. Following removal of the femoral head, acetabular exposure was completed, registration of the acetabulum was performed, and then the acetabulum was reamed using robotic guidance. Using the robotic arm, the appropriate acetabular cup implant and liner were impacted into place. The femur was then broached, and with femoral trials in place, a clinical evaluation of stability and navigation confirmation of stem version, leg length discrepancy (LLD), and offset, was performed. The femoral stem and head were implanted and a final confirmation of LLD, offset, and stability was recorded. The wound was closed by layers and a drain was placed. All THAs were performed using a cementless cup with polyethylene liner (Trinity; Corin, UK), uncemented stem (Metafix; Corin, UK), and a ceramic head (Biolox Delta; CeramTec, Plochingen, Germany).

Postoperative rehabilitation {#Sec5}
----------------------------

Patients in both cohorts were transferred to recovery suites. Patients in the outpatient cohort were discharged after medical stabilization, pain management, and initiation of ambulation as soon as the patient was alert and showed adequate stability and strength. Patients in the inpatient cohort were admitted at least for one night, after which they were similarly discharged, if medically stable.

The majority of patients were discharged home (\> 90%) with a minority discharged to skilled nursing facilities (\< 10%). Patients continued physical therapy for six to eight additional weeks and had follow-up appointments at 2 weeks, 1 month, and annually thereafter. PROs and complications were collected at the preoperative visit and each subsequent postoperative follow-up visit.

Results {#Sec6}
=======

Demographics {#Sec7}
------------

Our patient selection process is illustrated in Fig. [1](#Fig1){ref-type="fig"}. Following the matching process, 91 outpatient cases were matched to 91 inpatient cases. In the outpatient group, there were 38 (41.8%) females and 53 (58.2%) males, and in the inpatient group, there were 42 (46.2%) females and 49 (53.8%) males (*P* = 0.654). In addition, there were no significant differences in age or BMI between the two groups (Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}). In the outpatient group, there were 7 current smokers, and in the inpatient group, there were 8 current smokers (*P* = 0.788). With regard to Charlson Comorbidity Index, there was a similar distribution between the outpatient and inpatient groups (*P* = 0.984). In both groups, there were 9 patients with a CCI ≥ 3 and the majority of patients had an ASA score of 2. There was no significant difference in surgical time or blood loss between the two groups (*P* \> 0.05). Fig. 1Patient selection flow diagram. THA: total hip arthroplastyTable 1Summary demographics for both groupsOutpatientInpatient*P* valueHips included in study9191 Left44 (48.4%)43 (47.3%)0.882 Right47 (51.6%)48 (52.7%)Gender Female38 (41.8%)42 (46.2%)0.654 Male53 (58.2%)49 (53.8%)Approach Anterior87 (95.6%)86 (94.5%)0.732 Posterior4 (4.4%)5 (5.5%)Age at surgery (years, mean, SD, range)53.3 ± 7.2 (29.6- 65.8)55.3 ± 6.9 (36.9 - 75.8)0.12BMI (kg/m^2^, mean, SD, range)29.2 ± 5.2 (15.4- 44.3)29.4 ± 5.8 (20.6- 47.8)0.568Charlson Comorbidity Index, *n* 021 (23.1%)20 (22.0%)0.984 1--261 (67.0%)62 (68.1%) ≥ 39 (9.9%)9 (9.9%)*SD* standard deviation, *BMI* body mass index, *n* sample size, *mo* monthsTable 2Intraoperative data for both groupsOutpatientInpatient*P* valueFollow-up (mo, mean, SD)34.9 ± 7.2 (24.0--55.6)37.8 ± 8.5 (24.0--57.6)0.019ASA Score^1^0.076 114 (16.5%)18 (20.0%) 261 (71.8%)51 (56.7%) 310 (11.8%)21 (23.3%)Surgical time (min, mean, SD)113.6 ± 30.1116.1 ± 27.40.794Blood loss (mL, mean, SD)338.7 ± 187.6396.1 ± 242.10.083Hours at surgery center/hospital (hours, mean, SD)6.8 ± 1.443.2 ± 20.3\< 0.001Cup inclination (mean, SD)41.0 ± 3.440.7 ± 3.30.543Cup version (mean, SD)19.5 ± 4.319.5 ± 3.80.971Leg length discrepancy (mm, mean, SD)0.13 ± 3.00.96 ± 3.30.162Global offset (mm, mean, SD)72.5 ± 7.673.6 ± 6.00.288^1^ASA score only available for 85 outpatient cases and 90 inpatient cases*SD* standard deviation

Patient-reported outcomes {#Sec8}
-------------------------

The mean preoperative mHHS scores for the outpatient and inpatient groups were 15.3 ± 5.7 and 16.9 ± 9.1, respectively (*P* = 0.591). There was no significant difference in preoperative PROs or preoperative pain (VAS) between the two groups (Table [3](#Tab3){ref-type="table"}). Two-year postoperative PROs for the outpatient and inpatient groups are summarized in Table [4](#Tab4){ref-type="table"}. Outpatient cases demonstrated significantly higher mHHS and HHS scores at latest follow-up (91.5 ± 14.7 vs. 86.2 ± 17.1, *P* = 0.023 and 92.3 ± 13.4 vs. 87.4 ± 15.6, *P* = 0.023, respectively) (Fig. [2](#Fig2){ref-type="fig"}a). With regard to FJS, VR-12M, VR-12P, SF-12M, and SF-12P scores, there was no significant difference between the two groups (*P* \> 0.05). Outpatient cases experienced significantly less pain than inpatient cases (1.0 ± 2.0 vs 1.5 ± 2.2, *P* = 0.0434) at 2 years postoperatively (Fig. [2](#Fig2){ref-type="fig"}b). The mean satisfaction with surgery was 9.2 out of 10 in the outpatient group and 8.8 out of 10 in the inpatient group (*P* = 0.336). Table 3Preoperative patient-reported outcomes for both groupsPatient-reported outcomeOutpatientInpatient*P* valuemHHS (mean, SD, range)15.3 ± 5.7 (10--30)16.9 ± 9.1 (0--44)0.591HHS (mean, SD, range)14.8 ± 2.1 (9--18.1)13.7 ± 2.7 (9--18.1)0.057VR-12 M (mean, SD, range)32.3 ± 7.5 (20.6--53.4)30.0 ± 7.8 (14.9--52.8)0.168VR-12P (mean, SD, range)53.7 ± 10.9 (30.7--65.9)53.2 ± 10.6 (25.4--67.6)0.756SF-12 M (mean, SD, range)48.4 ± 13.6 (20--78)48.2 ± 18.7 (0--83)0.837SF-12P (mean, SD, range)52.6 ± 11.1 (27.7--66.2)51.1 ± 11.4 (26.3--66.2)0.522VAS (mean, SD, range)6.4 ± 2.3 (0--10)5.2 ± 3.0 (0--10)0.057*SD* standard deviation, *mHHS* modified Harris Hip Score, *HHS* Harris Hip Score, *VR-12M* Veterans RAND 12-Item Health Survey Mental, *VR-12P* Veterans RAND 12-Item Health Survey Physical, *SF-12M* Short Form 12 Mental, *SF-12P* Short Form 12-PhysicalTable 4Two-year patient-reported outcomes for both groupsPatient-reported outcomeOutpatientInpatient*P* valuemHHS (mean, SD, range)91.5 ± 14.7 (35.0--100)86.2 ± 17.1 (30.0--100)0.023HHS (mean, SD, range)92.3 ± 13.4 (40.9--100)87.4 ± 15.6 (36.3--100)0.023FJS (mean, SD, range)80.0 ± 22.7 (18.8--100)71.2 ± 30.8 (0--100)0.169VR-12 M (mean, SD, range)62.1 ± 5.5 (43.6--69.7)60.4 ± 8.0 (23.0--69.7)0.156VR-12P (mean, SD, range)51.4 ± 8.9 (13.9--59.5)48.9 ± 10.6 (14.6--60.3)0.121SF-12 M (mean, SD, range)57.7 ± 5.4 (34.6--69.4)56.3 ± 7.9 (22.9--70.5)0.375SF-12P (mean, SD, range)49.8 ± 9.5 (16.1--58.6)47.4 ± 11.0 (17.0--58.8)0.132VAS (mean, SD, range)1.0 ± 2.0 (0--8.44)1.5 ± 2.2 (0--10)0.043Satisfaction (mean, SD, range)9.2 ± 1.5 (2--10)8.8 ± 1.9 (0--10)0.336*SD* standard deviation, *mHHS* modified Harris Hip Score, *HHS* Harris Hip Score, *FJS* Forgotten Joint Score, *VR-12M* Veterans RAND 12-Item Health Survey Mental, *VR-12P* Veterans RAND 12-Item Health Survey Physical, *SF-12M* Short Form 12 Mental, *SF-12P* Short Form 12-PhysicalFig. 2**a** Mean ± SD, mHHS: modified Harris Hip Score, HHS: Harris Hip Score, FJS: Forgotten Joint Score. **b** Mean ± SD, VAS: visual analog scale

Revisions, complications, and unplanned clinic visits {#Sec9}
-----------------------------------------------------

The number of complications as classified according to the Clavien-Dindo system is provided in Table [5](#Tab5){ref-type="table"}. There was no significant difference in the type of complications experienced in both groups (*P* = 0.211). Two patients (2.2%) in the inpatient group underwent a revision THA for acetabular cup loosening at 1.5 and 2 years after the index surgery. There were no patients in the outpatient group that required a revision THA. All outpatient cases were discharged home the day of surgery. For the inpatient group, 84 (92.3%) were discharged home and 7 (7.7%) were discharged to an extended care facility or rehabilitation center. The total number of unplanned office visits and ER visits is detailed in Table [6](#Tab6){ref-type="table"}. Table 5Complications for both groupsComplicationsOutpatientInpatient*P* valueClavien-Dindo Classification0.211 I**10 (11.0%)10 (11.0%)**  Wound dehiscence6 (6.6%)1 (1.1%)  Periprosthetic/calcar fracture2 (2.2%)--  Greater trochanteric fracture--1 (1.1%)  Iliopsoas tendinitis--1 (1.1%)  Urinary retention/constipation--3 (3.3%)  Rash2 (2.2%)1 (1.1%)  Allergic reaction to narcotics--1 (1.1%)  Sciatica--1 (1.1%)  Psychiatric issues--1 (1.1%) II**1 (1.1%)4 (4.4%)**  Urinary tract infection1 (1.1%)1 (1.1%)  Anemia requiring transfusion--2 (2.2%)  ER visit for pain management--1 (1.1%) IIIa**03 (3.3%)**  Incision revision--3 (3.3%)Table 6Unplanned Office/ER VisitsUnplanned office/ER visitsOutpatientInpatient*P* valueUnplanned office visits9 (9.9%)3 (3.3%)0.135ER visits2 (2.2%)2 (2.2%)\> 0.999*ER* emergency room

Discussion {#Sec10}
==========

Compared to an inpatient group with similar age, sex, BMI, laterality, approach, Charlson Comorbidity Index (CCI), and smoking status, the outpatient group demonstrated superior outcomes at minimum 2 years postoperatively. There were significant differences in mHHS (91.5 vs. 86.2), HHS (92.3 vs. 87.4), and pain (1.0 vs. 1.5) at the latest follow-up. In addition, although not statistically significant, the outpatient group exhibited higher FJS at the latest follow-up (80.0 vs. 71.2, *P* = 0.17). Existing literature on outpatient THA focuses on perioperative patient safety as manifested in 90-day complication rates and readmissions. To date, there is only one study that directly compares inpatient and outpatient THA outcomes, and PROs were analyzed at 4-weeks postoperatively \[[@CR18]\]. To our knowledge, this is the first study to compare 2-year PROs between an outpatient and inpatient THA group.

As the patient populations were matched for multiple variables, the reason for the improved outcomes in the outpatient population warrants discussion. One possibility that needs to be considered is the socioeconomic background of the patients. It is possible that despite the matching process, the inpatient population may have had a less robust home-based support system or been of lower socioeconomic status. Social support, including having someone to discuss concerns, reinforce goals, and provide daily care, can increase a patient's self-efficacy during the sensitive postoperative period \[[@CR19], [@CR20]\]. In addition, socioeconomic status has been shown to influence both immediate and long-term outcomes following THA \[[@CR21]--[@CR23]\]. Another possibility may be the satisfaction with the surgical experience as this has been shown to influence post-surgical PROs \[[@CR24]\]. Lastly, the length of stay was significantly longer in the inpatient group, at nearly 2 days. This may influence the immediate postoperative course, including sleep quality, nutrition, and comfort levels, which may in turn impact long-term outcomes.

There were no significant differences in ASA scores, length of surgery, and blood loss between the two groups. The reduction in length of hospital stay in the outpatient group was very significant (6.8 h vs. 43.2 h, *P* \< 0.001). Based on the 2017 American Hospital Association (AHA) Annual Survey, the average expense per inpatient day in the USA is \$2,424 \[[@CR25]\]. Applying this data to our study, performing THA on an outpatient basis represents a savings of \$3,676 per patient.

Several studies have reported a \> 90% same-day discharge rate in patients undergoing outpatient THA \[[@CR5], [@CR26], [@CR27]\]. A systematic review on 955 patients undergoing outpatient total joint arthroplasty (TJA) found that 94.7% of patients were discharged the same day \[[@CR28]\]. In this study, all patients in the outpatient group met the discharge criteria and were discharged home the day of surgery, as planned. Same-day discharge has been facilitated by a number of factors, including proper patient selection for outpatient surgery, comprehensive preoperative patient education, and an optimized perioperative rapid recovery protocol.

In addition, we evaluated readmissions, visits to the emergency room, and unplanned clinic visits. We did not detect any statistically significant differences in these measures, although this study may have been underpowered in this respect. There were no 90-day readmissions in the outpatient group, and there was one readmission for wound revision in the inpatient group. In a study on 250,000 THAs using the Nationwide Readmissions Database, the rates of 30- and 90-day readmissions after THA were 4% and 8%, respectively. The authors found that a patient's length of stay had the greatest influence on the cost of 90-day readmissions \[[@CR29]\]. In studies on outpatient TJA, rates of 90-day readmission are very low, at approximately 0.5--1% \[[@CR28], [@CR30]\].

There are mixed findings on whether performing TJA on an outpatient basis increases the burden on the surgeon. Shah et al. found that outpatient TJA shifts the burden of care from the hospital to the surgeon, as outpatient surgery requires increased preoperative patient education and results in more patient phone calls the week following surgery \[[@CR31]\]. Conversely, in a multi-center, prospective, randomized study, Goyal et al. found no significant difference in the outpatient and inpatient THA group with regard to calls between the office staff and patients \[[@CR18]\].

The primary concern in performing outpatient THA has been patient safety and complications. Based on the findings in this study, there were no significant differences between the two groups in complication rates. In several studies, in appropriately selected patients, complications have been shown to be equal or lower in patients undergoing outpatient THA. Courtney et al. analyzed the American College of Surgeons-National Surgical Quality Improvement Program (ACS-NSQIP) database and found an 8% complication rate in the outpatient setting compared to a 16% complication rate in the inpatient setting \[[@CR30]\]. Arshi et al. performed a registry-based study on 2184 patients undergoing outpatient THA and found comparable rates of surgical and medical complications \[[@CR32]\].

It is noteworthy that seven patients in both groups combined experienced wound healing complications, although without further deep infections. All patients improved with local wound care and oral or topical antibiotics. The relatively higher rate of wound complications in this series can be explained by the predominant utilization of the direct anterior approach in patients included in this study. Multiple studies have demonstrated increased rates of wound complication when comparing the direct anterior approach to other surgical approaches \[[@CR33]--[@CR36]\].

There are multiple notable strengths in the present study. First, outpatient cases were matched to a contemporary group of inpatient cases with similar age, sex, BMI, laterality, approach, Charlson Comorbidity Index (CCI), and smoking status. Second, the patients included in the outpatient cohort were a prospectively selected, consecutive series of patients which enabled consistent data acquisition, and reduced selection bias. Third, this study analyzed multiple outcomes, including several PROs, readmissions, 90-day complications, unplanned office visits, and a 2-year revision rate. Fourth, by analyzing a single surgeon's patient population, performance bias may be minimized enabling direct comparison between the inpatient and outpatient setting. This consistency is evident in the almost identical radiographic outcomes following surgery.

This study is not without limitations. Our study population included a younger than average cohort, with the average age being 53 and 55 for the outpatient and inpatient groups, respectively. Studies on outpatient THA have tended to consist of patients that are younger than the general population undergoing THA \[[@CR28]\]. In a multi-national study on nearly 500,000 THA procedures, more than 60% of patients were aged 60--79, with only 13--20% belonging to the 50--59 age group \[[@CR37]\]. This discrepancy is multifactorial, stemming from the senior author's practice, which includes a younger, more active patient population, and the inherently younger cohort of inpatient THA cases needed to match the age of the outpatient THA group. Therefore, conclusions from this study may not be applicable to an older, more morbid patient population.

Second, the choice to undergo an inpatient or an outpatient procedure is determined by multiple factors, several of which depend on patient comorbidities. For the purpose of this study, we utilized a propensity-score matching process that consisted of several variables including medical comorbidities, smoking status, age, and BMI. Despite this matching process, the inpatient group had more patient graded ASA 3, although this was not statistically significant.

Additionally, this study consists of a mixed group of anterior and posterior THAs. However, in both groups, the patients undergoing posterior THA represented a small minority (4.4% and 5.5% for inpatient and outpatient cohorts, respectively).

Fourth, although we addressed postoperative follow-up in readmissions, emergency room visits, and unplanned office visits, we did not account for additional phone calls between the office staff and patients. This was inconsistently recorded and therefore was omitted from our analysis.

Lastly, this study was based on a single surgeon's practice, which may limit the generalizability of our results. This practice is a high-volume practice, with extensive experience operating in the outpatient setting, including arthroscopic and arthroplasty procedures. The workflow developed by the surgeon and the office staff to optimize outpatient management may be difficult to apply to smaller practices.

Conclusion {#Sec11}
==========

In conclusion, in appropriately selected, younger patients, outpatient THA can achieve improved postoperative patient-reported outcomes compared to inpatient THA. At 90-days postoperatively, we found similar readmission rates, unplanned office and emergency room visits, and complication rates between the two groups. At 2 years postoperatively, no significant differences were found in revision rates.
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